News & Updates

A retrospective study in Hong Kong has shown that stereotactic body radiotherapy (SBRT) is an effective and well-tolerated treatment for patients with unresectable liver metastases.

A breast cancer diagnosis may just be right at our fingertips, literally.

Individuals with germline genetic alterations, particularly the BRCA1/2 pathogenic/likely pathogenic variant (PV/LPV), do not appear to experience any significant increase in post-COVID vaccination side effects, as reported in a study from Singapore.

In the management of advanced cancers, physicians and their patients may prefer treatment with nivolumab 3 mg/kg biweekly, nivolumab 240 mg weekly, or nivolumab 3 mg/kg plus ipilimumab 1 mg/kg triweekly due to their relatively low risk of treatment-related adverse events (TRAEs), treatment discontinuation due to TRAEs (TDAE), and serious adverse events (SAEs), suggests a study.

Oncologists underestimate patients’ willingness to attend appointments to avoid treatment interruptions during the COVID-19 pandemic, according to a multidisciplinary cross-sectional survey, which shows unaltered willingness to attend scheduled appointments in most cancer patients.

New drug applications approved by US FDA as of 16-30 April 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.